Pharma, Medical Device Provisions Outlined In Korea, EU Free Trade Agreement
This article was originally published in The Pink Sheet Daily
Fair, transparent, reasonable and non-discriminatory rules urged for pricing and reimbursement processes.
You may also be interested in...
South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig
HONG KONG - South Korea needs to clarify drug pricing regulations and speed up its decision-making process for new products if it hopes to attract, or even maintain, investment in the R&D pharmaceutical space
SEOUL - South Korean trade associations representing both multinational and local pharmaceutical companies told the government that their members will accept the government's new guidelines that classify meals provided to doctors and pharmacists worth more than KRW 100,000 ($80) as illegal kickbacks
SEOUL - The conclusion of the Free Trade Agreement talks on July 13 with the European Union could deal another blow to generic-dependent local South Korean pharma companies, already hit by a similar pact pending with the U.S